Details for Patent: 6,759,398

✉ Email this page to a colleague

Summary for Patent: 6,759,398

Title:	Anti-inflammatory androstane derivative
Abstract:	According to one aspect of the invention, there is provided a pharmaceutical formulation for administration by inhalation comprising a compound of formula (I), ##STR1## or a solvate thereof, together with a long-acting .beta..sub.2 -adrenoreceptor agonist which formulation has a therapeutically useful effect in the treatment of inflammatory disorders of the respiratory tract over a period of 24 hours or more.
Inventor(s):	Biggadike; Keith (Stevenage, GB)
Assignee:	SmithKline Beecham Corporation (Philadelphia, PA)
Application Number:	10/066,836
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 6,759,398
Patent Claim Types: see list of patent claims	Formulation; Compound; Use; Composition; Delivery;

Drugs Protected by US Patent 6,759,398

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 6,759,398

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	0019172	Aug 05, 2000

International Family Members for US Patent 6,759,398

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	1305329	⤷ Sign Up	91429	Luxembourg	⤷ Sign Up
European Patent Office	1305329	⤷ Sign Up	CA 2008 00022	Denmark	⤷ Sign Up
European Patent Office	1305329	⤷ Sign Up	300343	Netherlands	⤷ Sign Up
European Patent Office	1305329	⤷ Sign Up	SPC011/2008	Ireland	⤷ Sign Up
European Patent Office	1305329	⤷ Sign Up	08C0014	France	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.